Synonym: (1R*,2S*,3R*,4S*)-N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-2,3-norbornanedicarboximide citrate salt; SM 3997
CAS Number: 87760-53-0
Empirical Formula (Hill Notation): C21H29N5O2
Molecular Weight: 383.49
Linear Formula: C21H29N5O2
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts T6704-25MG.
| assay |
≥98% (HPLC) |
| InChI |
1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18- |
| InChI key |
CEIJFEGBUDEYSX-FZDBZEDMSA-N |
| originator |
Dainippon Sumitomo |
| Quality Level |
100  |
| SMILES string |
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN4CCN(CC4)c5ncccn5 |
| solubility |
DMSO: 38 mg/mL |
| storage condition |
protect from light |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Tandospirone is a partial agonist at 5HT1A receptors. |
| Biochem/physiol Actions: |
Tandospirone is a partial agonist at 5HT1A receptors. It significantly reduces haloperidol-induced bradykinesia in a dose-dependent manner. The potency of tandospirone is equal to that of buspirone and approximate half that of diazepam. The potency of tandospirone as a dopamine antagonistic is less than 1/4 that of buspirone. |
| Features and Benefits: |
This compound was developed by Dainippon Sumitomo . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
5, 25 mg in glass bottle |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
51111800 |